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Purpose: To investigate the preoperative prognostic factors contributing to extremely poor visual
outcome in cases of proliferative diabetic retinopathy after a successful vitrectomy and an uneventful
postoperative course.
Methods: We enrolled 28 consecutive eyes of 28 patients with poor preoperative visual acuity (VA), who
underwent primary diabetic vitrectomy. The postoperative course was uneventful, and retinal attach-
ment was achieved for at least 6 months in all cases. The cases were separated into the study group
(postoperative VA < preoperative VA) and control group (postoperative VA  preoperative VA). Preop-
erative factors including systemic diseases, demographic data, proliferative diabetic retinopathy severity,
and neovascularization status were compared between the two groups. Signiﬁcant risk factors for poor
visual results were determined by logistic regression analysis.
Results: The creatinine level was signiﬁcantly higher in the study group (4.07 ± 4.15 mg/dL) than in the
control group (1.23 ± 0.46 mg/dL; p ¼ 0.003). Chronic macular detachment was noted in 7/10 eyes (70%)
in the study group and in 1/18 eyes (5.6%) in the control group (p ¼ 0.001). Broad ﬁbrovascular prolif-
eration extending to the periphery for more than two quadrants was found in 4/10 eyes (40%) in the
study group and in none of the eyes in the control group (p ¼ 0.016). Chronic macular detachment and
broad ﬁbrovascular proliferation were signiﬁcantly associated with poor visual outcome in multiple
logistic regression analysis.
Conclusion: Preoperative chronic macular detachment, broad ﬁbrovascular proliferation, and poor renal
function may indicate worse visual results after successful diabetic vitrectomy for cases with severe
diabetic retinopathy.
Copyright © 2014, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Vitrectomy is the major treatment modality for severe pro-
liferative diabetic retinopathy (PDR).1 With advances in both the
understanding of pathoanatomy and vitrectomy techniques and
instruments, a high anatomical success rate can be achieved in
eyes with severe PDR. However, improvement of visual outcome
might not occur in all cases. Various pre- and postoperative
factors associated with a poor visual outcome have beenof interest to declare.
ology, National Taiwan Uni-
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ciety of Taiwan. Published by Elsereported in the literature, including poor preoperative visual
acuity (VA), older age, iris neovascularization,2e4 a history of
lensectomy, the creation of iatrogenic breaks, and elevated
intraocular pressure.5,6 Although these studies provide impor-
tant information regarding the association between the periop-
erative conditions and the anatomical and functional outcomes,
few studies have speciﬁcally focused on the preoperative sys-
temic and local factors that may be related to an extremely poor
visual function despite an anatomical success and an uneventful
postoperative course. In this study, we selected patients with
poor initial vision who had obtained a successful anatomical
outcome after an uneventful surgery and who experienced a
smooth postoperative course. Cases with an extremely poor
functional outcome (VA less than counting ﬁngers) were
compared with those that had a better visual outcome. Preop-
erative systemic and local factors were examined to identifyvier Taiwan LLC. All rights reserved.
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outcome in severe PDR. The identiﬁcation of these factors may be
useful for predicting poor functional outcome and avoiding un-
necessary surgical interventions.
2. Patients and methods
From January 2009 to March 2012, the clinical records of
consecutive patients with poor preoperative VA (less than counting
ﬁngers) who underwent primary pars plana vitrectomy for com-
plications of PDR were reviewed retrospectively. All cases were
postoperatively followed up for >6 months. Patients with retinal
attachment at the end of the surgery, an uneventful postoperative
course, regular postoperative follow-up, and postoperative retinal
attachment for at least 6 months were enrolled. Patients who had
elevated intraocular pressure of > 35 mmHg for 2 consecutive
postoperative days and patients who had signiﬁcant vitreous
hemorrhage and/or dense cataract before the surgery were
excluded. Thus, only those cases whose visual function reﬂected
the severity of the anatomical changes were selected. The study
cases were separated into two groups according to the post-
operative VA. We deﬁned the study group as cases with a post-
operative VA that was worse than the preoperative VA (hand
motion, light perception, or no light perception) and the control
group as cases with a postoperative VA better than the preoperative
VA (counting ﬁngers or any Snellen acuity). The postoperative VA
was measured at least 6 months postoperatively. This study was
approved by the ethics board of the National Taiwan University
Hospital, Taipei, Taiwan.
2.1. Surgical technique
All of the surgeries were performed by one surgeon (C.M.Y.)
using a standard three-port pars plana vitrectomy, as described
previously.7,8 Brieﬂy, a 20-gauge vitrectomy system was set up in
every case. Anterioreposterior traction release was attempted ﬁrst,
followed by ﬁbrovascular tissue removal with delamination as the
principal technique. Hemostasis was achieved by raising the infu-
sion bottle and applying mechanical compression with a soft-
tipped cannula, endodiathermy, or a combination of the above
techniques. Fluideair exchange with internal drainage of the sub-
retinal ﬂuid was performed through preexisting or iatrogenic
breaks followed by supplementary panretinal photocoagulation
extending beyond the equator and peripheral cryotherapy. Long-
acting gas (15e20% C3F8) or silicone oil (5000 cs) infusion was
performed if needed. In certain cases, a 360 encircling buckle was
placed to counter any possible residual peripheral vitreous traction.
Bevacizumab (0.05 mg) was injected through an upper sclerotomy
with an insulin syringe in every case.
The demographic data of the patients and the preoperative and
intraoperative factors associated poor visual outcome were recor-
ded in detail. The investigated preoperative general factors
included sex, age, and underlying systemic diseases as well as local
factors, including lens status, the presence or absence of chronic
long-standing macular detachment, the extent of ﬁbrovascular
proliferation, predominantly active or inactive neovascularization,
the extent of retinal detachment, and the existence or lack of iris
neovascularization.
Chronic long-standingmacular detachment was deﬁned as four-
quadrant vessel sheathing, a pale disc, uniformly ﬁbrotic prolifera-
tion, and atrophic thinning of the detached macula if optical
coherence tomography datawere available. A predominantly active
neovascularization was deﬁned as the presence of visible neo-
vascularization in the larger part of the proliferative tissue with any
degree of vitreous hemorrhage, and a predominantly inactiveneovascularizationwas deﬁned as a fundus status in which most of
the proliferative tissue appeared avascular. The extent of ﬁbrovas-
cular proliferation were classiﬁed as follows: Grade 0, a lack of
adhesion or only focal adhesion; Grade 1, a broad adhesion of less
than or equal to three sites; Grade 2, a broad adhesion of more than
three sites, without extension to the periphery; Grade 3, a broad
adhesion ofmore than three sites that extended to the periphery for
less thanor equal to twoquadrants; andGrade4, a broad adhesion of
more than three sites that extended to the periphery for more than
two quadrants.9 The extent of retinal detachment was classiﬁed as
follows: localized only to the macular area, outside of the arcade for
 2 quadrants, or outside of the arcade for > 2 quadrants.
To calculate the VA, vision of counting ﬁngers, hand motion,
light perception, and no light perception were respectively deﬁned
as a Snellen chart of 0.005, 0.002, 0.001, and 0.0005 and were
subsequently converted to 2.3, 2.7, 3.0, and 3.3 logMAR units.10
2.2. Statistical analysis
To examine the signiﬁcance of predisposing factors correlated
with poor visual outcome between the study group and the control
group, the Chi-square test or Fisher's exact test was performed for
categorical variables and the ManneWhitney U test was used for
continuous variables. Fundus characteristic variables that appeared
to have a possible association with visual outcome were ﬁrst
assessed by univariate logistic regression analysis. Signiﬁcant fac-
tors were entered into a model using multiple logistic regression
with the forward conditional method to verify the correlations
further. All statistical analyses were conducted with SPSS statistics
17.0 (SPSS Inc., Chicago, IL, USA). A p value of < 0.05 was considered
statistically signiﬁcant.
3. Results
We enrolled 10 eyes of 10 patients (8 women and 2 men) in the
study group and 18 eyes of 18 patients (14 women and 4 men) in
the control group. The demographic data, preoperative clinical
ﬁndings, and functional outcomes of all patients are listed in
Table 1. The preoperative VA of both groups was less than counting
ﬁngers, and no signiﬁcant difference was found in terms of age and
preoperative VA between the two groups (p ¼ 0.11 and p ¼ 0.25,
respectively). The mean postoperative VAs of the study group and
the control group were 2.88 ± 0.29 logMAR units and 1.55 ± 0.52
logMAR units, respectively (p < 0.001). The mean improvement of
the VA was 0.12 ± 0.29 logMAR units in the control group
and 0.16 ± 0.52 logMAR units in the study group (p < 0.001;
Table 2). The clinical features of both groups are listed in Table 3.
Regular hemodialysis was performed in 3 of 10 patients (30%) in the
study group, but in none of the patients in the control group.
Furthermore, the creatinine level was signiﬁcantly higher in the
study group (4.07 ± 4.15 mg/dL) than in the control group
(1.23 ± 0.46 mg/dL; p ¼ 0.003). Chronic long-standing macular
detachment was noted in seven of 10 eyes (70%) in the study group,
but in only one of 18 eyes (5.6%) in the control group (p ¼ 0.001).
Four of 10 eyes (40%) in the study group had ﬁbrovascular prolif-
eration extending to the periphery for more than two quadrants,
whereas all of the eyes in the control group contained ﬁbrovascular
tissue extending to the periphery for less than two quadrants
(p ¼ 0.016). Combined traction and rhegmatogenous retinal
detachment was found in seven of 10 eyes (70%) in the study group
and in nine of 18 (50%) eyes in the control group (p¼ 0.43). Cataract
surgery was performed in the same setting in ﬁve of 10 eyes (50%)
in the study group and in two of 18 eyes (11.1%) in the control group
(p ¼ 0.063; Table 3). When fundus variables were applied as pa-
rameters, univariate analysis showed that chronic long-standing
Table 1
Demographic data of all patients.
Patient
no.
Sex/age Systemic diseases Fundus ﬁndings Intraoperative factor BCVA LogMAR BCVA
HTN Hb Cr. HD Atrophic
retina
pattern
FVP
level
Fibrosis RD area Iris NV Bleeding
tendency
Combined
cataract
operation
Preop VA Postop VA Preop VA Postop VA
1 F/51 þ 12 2.5  þ 4 Inactive Macula  Minor þ HM 1 m HM 15 cm 2.7 2.7
2 F/62 þ  þ 2 Inactive Macular  Moderate þ HM 10 cm HM 30 cm 2.7 2.7
3 F/55 þ 13.5 1.5  þ 3 Inactive Macula  Minimal þ CF 5 cm HM 20 cm 2.3 2.7
4 F/58 þ 11.7 5.3 þ þ 3 Inactive Macula  Minimal þ HM 80 cm HM 15 cm 2.7 2.7
5 M/52 þ 8.4 13.78 þ þ 4 Inactive Total  Minor þ LP HM < 1 m 3 2.7
6 F/62 þ 9.9 3.4   1 Active Macula  Minor  HM 30 cm HM 1 m 2.7 2.7
7 F/61 þ þ  4 Inactive Total þ Moderate þ LP NLP 3 3.3
8 F/61 þ 12.4 3.3  þ 4 Inactive Macula   HM 15 cm NLP 2.7 3.3
9 M/59 þ 11.1 1.8   3 Active Macula  Severe  HM 60 cm HM 80 cm 2.7 2.7
10 F/48  12.6 1  þ 3 Inactive Macula  Minimal þ HM 1 m NLP 2.7 3.3
11 F/45 þ 2.2   2 Active Total   HM 60 cm 0.1 2.7 1
12 F/54 þ 11.6 0.8   2 Active Total  Minor þ HM 1 m 0.02 2.7 1.698
13 M/61  13.6 1.24   2 Active Macula  Minimal  CF 15 cm 0.1 2.3 1
14 M/54  15.2 1   2 Active Total  Moderate  HM 30 cm 0.15 2.7 0.823
15 F/60 þ 11.8 1.6   1 Inactive Macula  Minimal  HM 40 cm CF 20 cm 2.7 2.3
16 F/53 þ 11.1 1.8   2 Active Total  Minimal  HM 30 cm 0.03 2.7 1.522
17 F/55 þ 8 2  þ 0 Active Macula  þ HM 1 m 0.03 2.7 1.522
18 F/55 þ 12.5 1   2 Inactive Macula  Minimal  CF 20 cm 0.03 2.3 1.522
19 F/55  11.5 1.2   0 Active Total  Minimal þ LP 0.02 3 1.698
20 F/55 þ 12.2 1.2   3 Inactive Macula  Minor þ HM 1 m 0.1 2.7 1
21 F/60  11.4 0.9   3 Active Macula þ Moderate  HM 80 cm CF 70 cm 2.7 2.3
22 F/48 þ 10.4 1.6   0 Active Macula  Minimal  CF 10 cm 0.02 2.3 1.698
23 F/69  12.6 0.7   3 Inactive Total  Minimal þ HM 1 m 0.01 2.7 2
24 M/44  14.7 1   2 Active Total  Minimal þ HM 50 cm 0.05 2.7 1.301
25 F/44 þ 12.7 0.8   3 Active Macula  Minor þ HM 1 m 0.1 2.7 1
26 M/50    1 Active Macula   CF 20 cm CF 10 cm 2.3 2.3
27 F/55  12.7 0.7   3 Inactive Macula  Minimal þ HM 80 cm CF 30 cm 2.7 2.3
28 F/41 þ 10.8 1.1   2 Active Total  Minimal þ CF 25 cm 0.1 2.3 1
BCVA¼ best corrected visual acuity; CF¼ counting ﬁngers; Cr.¼ creatinine; F¼ female; FVP¼ ﬁbrovascular proliferation; Hb¼ hemoglobulin; HD¼ hemodialysis; HM¼ hand
motions; HTN ¼ hypertension; LP ¼ light perception only; M ¼ male; NLP ¼ no light perception; NV ¼ neovascularization; preop ¼ preoperative; postop ¼ postoperative;
RD ¼ retinal detachment; VA ¼ visual acuity.
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retinal ﬁbrosis were signiﬁcantly associated with a poor prognosis
(p ¼ 0.003, p ¼ 0.018, and p ¼ 0.014, respectively). Multiple logistic
regression analysis indicated that chronic long-standing macular
detachment (p ¼ 0.023) and the extent of ﬁbrovascular prolifera-
tion (p ¼ 0.049) were the strongest risk factors for poor visual
outcome (Table 4). An example from the study group is shown in
Fig. 1 and an example from the control group is shown in Fig. 2.
4. Discussion
This study speciﬁcally focused on the preoperative factors that
contribute to extremely poor visual outcome (VA less than countingTable 2
Preoperative and postoperative logMAR visual acuity in study and control groups.
Preoperation Postoperation
Study gr.
(n ¼ 10)
Control gr.
(n ¼ 18)
Study gr.
(n ¼ 10)
Control gr.
(n ¼ 18)
BCVA
>Counting ﬁngers 0 0 0 13
Counting ﬁngers 1 5 7 4
Hand motion 7 12 0 0
Light perception 2 1 3 0
LogMAR VAa
(mean ± SD)
2.72 ± 0.19 2.61 ± 0.21 2.88 ± 0.29 1.55 ± 0.52
Improve LogMAR
VAa (mean ± SD)
0.16 ± 0.30 1.05 ± 0.55
BCVA ¼ best corrected visual acuity; gr. ¼ group; SD ¼ standard deviation;
VA ¼ visual acuity.
a All logMAR visual acuities are converted from Snellen visual acuity.ﬁngers, i.e., handmotion, light perception, or no light perception) in
eyes that have undergone successful surgery (100% reattachment
with at least 6 months of follow-up after surgery). Although a poor
preoperative VA is reportedly a negative predictive factor for vit-
rectomy in severe proliferative diabetic patients,1 it is this group of
patients who may beneﬁt most from VA gain via surgery. Although
all of the patients had a poor preoperative VA in our study (less than
counting ﬁngers), improved visual outcome was achieved in the
patients in the control group. Thus, the purpose of this study was to
identify other preoperative factors associated with extremely poor
visual function after an uneventful intra- and postoperative course
in this group of patients. Risk factors that have been described in the
literature as well as speciﬁc retinal ﬁndingswere examined in order
to correlate themwith theﬁnal visual outcome. The studygroup had
a signiﬁcantly higher creatinine level compared to the control group.
In addition, univariate statistical analysis using fundus variables as
risk factors revealed that chronic long-standing macular detach-
ment, the extent of ﬁbrovascular proliferation, and predominantly
inactive neovascularization were signiﬁcantly associated with a
poor prognosis. Multivariate analysis further showed that chronic
long-standing macular detachment and the extent of ﬁbrovascular
proliferation were the most important factors that determined the
ﬁnal poor visual outcome.
Both diabetic retinopathy and diabetic nephropathy are among
diabetic microvascular complications. The microangiopathy in the
kidney may indicate a similar microvascular environment in the
retina. In addition, the presence of one preexisting complication
(diabetic retinopathy, diabetic nephropathy, or diabetic neuropa-
thy) may contribute to the development of another complication.11
Our data showed that the patient's creatinine level and whether or
not the patient was undergoing hemodialysis were signiﬁcantly
Table 3
The clinical features of both study and control groups.
Study gr.
(n ¼ 10)
Control gr.
(n ¼ 18)
p
Sex (female/male) 8/2 14/4
Age 53.2 ± 7.04
(range 48e62)
56.9 ± 5.09
(range 44e69)
0.1
Chronic long-standing
macular detachment
7 (70) 1 (5.9) 0.001
FVP extent 0.021
Grade 0 0 (0) 3 (16.6)
Grade 1 1 (10) 2 (11.1)
Grade 2 1 (10) 8 (44.4)
Grade 3 4 (40) 5 (27.8)
Grade 4 4 (40) 0 (0)
FVP 3 quadrants 4 (40) 0 (0) 0.01
HTN 9 (90) 10 (55.6) 0.098
Hemodialysis 3 (3) 0 (0) 0.037
Creatinine 4.07 ± 4.15
(range 1.0e13.8)
1.23 ± 0.46
(range 0.7e2)
0.003
Hemoglobin 11.45 ± 1.63 12.05 ± 1.70 0.5
Iris NV 8 (80) 10 (55.6)
RD area 0.247
Macular and  2 quadrants 8 (80) 10 (55.6)
> 2 quadrants 2 (20) 8 (44.4)
Bleeding 0.326
Minor 3 (33.3) 13 (86.7)
Moderate to severe 6 (66.7) 2 (13.3)
Neovascular activity 0.125
Predominantly active 4 (40) 13 (72.2)
Predominantly inactive 6 (60) 5 (27.8)
Combined RD 7 (70) 9 (50) 0.434
Simultaneous cataract surgery 5 (50) 2 (13.3) 0.063
Data are presented as n (%) or mean ± SD.
FVP ¼ ﬁbrovascular proliferation; gr. ¼ group; HTN ¼ hypertension; RD ¼ retinal
detachment; SD ¼ standard deviation.
Fig. 1. (A) Fundus photograph of Patient 1 shows ﬁbrovascular proliferation with broad
adhesion of more than three sites that extend to the periphery for four quadrants
(Grade 4), chronic macular detachment, and predominantly inactive neo-
vascularization. (B) After the operation, the retina was attached but the visual acuity
remained hand motion. (C) Optical coherence tomography shows atrophic thinning of
the retina.
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renal function reﬂects the general worsening of the microvascular
environment. Surgery on a retina with extensively damaged
microcirculation and preexisting poor visual function may result in
a poor prognosis after surgery.
In our study, the extent of ﬁbrovascular proliferation was also
signiﬁcantly associated with a poor prognosis. Themost critical and
difﬁcult part of vitrectomy for severe PDR is the meticulous
dissection and removal of the preretinal membrane, and a favorable
anatomical result depends on the proper removal of the ﬁbrovas-
cular tissue. A ﬁbrovascular proliferation extending to the periph-
ery not only indicates a fulminant ﬁbrovascular proliferation, which
leads to a more distorted and detached macular, but also compli-
cates the surgery and prolongs the surgical period.9 The level ofTable 4
Logistic regression analysis for postoperative poor vision and fundus characteristic.
Factors Odds ratio Standard
error
p 95% conﬁdential
interval
Univariate
Chronic RD* 39.67 49.14 0.003 3.50e449.72
FVP level* 4.26 2.61 0.018 1.28e14.15
RD area 0.32 0.29 0.207 0.05e1.90
Fibrosis* 0.10 0.09 0.014 0.01e0.62
Combined RD 2.33 1.95 0.311 0.45e12.00
Multivariates
Chronic RD* 66.85 123.43 0.023 1.79e2493.25
FVP level* 3.99 2.81 0.049 1.00e15.87
Variables of fundus characteristics associated with visual outcome were ﬁrst
assessed using univariate logistic analysis. Signiﬁcant factors were entered into a
model using multivariate logistic regression by forward conditional method.
* p < 0.05, statistically signiﬁcant.
FVP ¼ ﬁbrovascular proliferation; RD ¼ retinal detachment.ﬁbrovascular proliferation was classiﬁed into ﬁve grades in our
study, andwe found that this level was signiﬁcantly associatedwith
visual outcome. None of the patients in the control group had
ﬁbrovascular proliferation extending beyond the equator for more
than two quadrants, whereas this was observed in 40% of the pa-
tients in the study group.
In this study, chronic long-standing macular detachment was
another factor correlated with poor visual outcome in our study.
Although this resultmay not be surprising, our literature review did
not ﬁnd reports discussing this fundus changes as a risk factor for
poor visual prognosis. In this study, we speciﬁcally deﬁned chronic
long-standing macular detachment as the presence of diffuse
vascular sheathing, atrophic thinning of the retina, uniformly
ﬁbrotic proliferation, and atrophic thin retina on optical coherence
tomography images. We found that fundus changes containing
these deﬁned features were indeed associated with poor visual
outcome. The PDR is no longer active when it has progressed to the
burned-out stage, and a reduction in the caliber of the retinal
vessels and sheathed vessels are often found in this stage. The
quiescent neovascular activity may also reﬂect atrophy of the
retina.12 Thus, a more advanced ﬁbrotic stage indicates a more
prolonged compromise of retinal conditions, which might be a
factor for a poor prognosis. Although predominantly inactive neo-
vascularization alone was not signiﬁcantly correlated with a poor
prognosis in our study (p ¼ 0.125), 60% of the patients in the study
group had predominantly inactive neovascularization compared to
only 28% of patients in the control group. As the PDR with macularFig. 2. (A) Fundus photograph of Patient 25 shows ﬁbrovascular proliferation with
broad adhesion of more than three sites that extend to the periphery for two quadrants
(Grade 3), and predominantly active neovascularization. (B) After the operation, the
retina was attached, and visual acuity improved to 0.1 from hand motion. (C) Vertical
section of the optical coherence tomography image shows attached retina without
central thinning.
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the macula, it usually reaches the atrophic stage. An atrophic optic
nerve can be a sign of chronic long-standing macular detachment
or compromised disc circulation secondary to ischemia, vitre-
opapillary traction, or unstable intraocular pressure.13 Although the
evolution of sophisticated vitrectomy instruments permits salvage
of many cases of severe PDR, chronic long-standing macular
detachment remains one of the most important indicators of poor
functional outcome. Our study suggests that the necessity of the
surgery should be reconsidered when signs such as a pale disc,
four-quadrant vessel sheathing, pure ﬁbrotic proliferation, and
atrophic thinning of the detached macula are observed.
Although previous studies have provided multiple predisposing
factors associated with poor visual outcome in vitrectomy for PDR,
this study speciﬁcally investigated the preoperative factors for the
most severe cases to evaluate the necessity of performing the sur-
gery. Patients who have signs of chronic long-standing macular
detachment, ﬁbrovascular proliferation extending beyond the
equator for more than two quadrants, and poor renal function,
especially those who are undergoing regular hemodialysis, might
be unsuitable candidates for surgery. Although we have found that
certain preoperative factors may be correlated with extremely poor
visual outcome and make surgical intervention a futile effort, it is
more important to know howeach factorweighed as a determinant
of the visual prognosis as well as if the presence of multiple risk
factors further increases the possibility of extremely poor ﬁnal
vision. Unfortunately, the small case number in the study group
prevented such an analysis.
Other limitations of our study included its retrospective nature
and the fact that the difference between the surgical procedures
was not considered between cases. Although study bias was inev-
itable, this was kept as minimal as possible by careful documen-
tation of the preoperative ﬁndings, which were conﬁrmed during
surgery, and by excluding patients with any surgical complications
during long-term follow-up. Our study had several strengths: we
excluded moderately severe cases by restricting the study group
only to those with extremely poor postoperative VA and excludedcases complicated by vitreous hemorrhage. In addition, we selected
those whose age and preoperative VA matched the control group
patients. With these restrictions, the preoperative fundus features
and systemic problems that are correlated with extremely severe
PDR could be identiﬁed. Further prospective studies with a larger
number size are necessary to conﬁrm our conclusion.References
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